Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV Vaccines Immunogenicity and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02405520
What this trial is testing

Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 145
Large-scale testing (Phase 3)Study completedNCT00578227
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 814
Testing effectiveness (Phase 2)Study completedNCT00693966
What this trial is testing

Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 210
Testing effectiveness (Phase 2)Looking for participantsNCT06756269
What this trial is testing

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

Who this might be right for
HPV InfectionHPV-Related CarcinomaHPV-Related Intraepithelial Neoplasia+1 more
Shanghai Bovax Biotechnology Co., Ltd. 330
Large-scale testing (Phase 3)Study completedNCT04508309
What this trial is testing

Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls

Who this might be right for
Cervical Cancer
PATH 1,025
Large-scale testing (Phase 3)Active Not RecruitingNCT03998254
What this trial is testing

Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 6,000
Early research (Phase 1)Study completedNCT07081334
What this trial is testing

PV-001 9-valent Human Papillomavirus(HPV) Vaccine

Who this might be right for
HPV Infections
POSVAX 41
Large-scale testing (Phase 3)Active Not RecruitingNCT04708041
What this trial is testing

Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 700
Not applicableStudy completedNCT00786409
What this trial is testing

Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women

Who this might be right for
Systemic Lupus Erythematosus
University of Chicago 27
Large-scale testing (Phase 3)Study completedNCT00369824
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,330
Large-scale testing (Phase 3)Study completedNCT00496626
What this trial is testing

An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 600
Large-scale testing (Phase 3)Study completedNCT01254643
What this trial is testing

The Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008).

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 100
Early research (Phase 1)Study completedNCT00478621
What this trial is testing

Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 540
Post-approval studies (Phase 4)Study completedNCT00911521
What this trial is testing

Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study

Who this might be right for
Systemic Lupus Erythematosus
Tuen Mun Hospital 100
Large-scale testing (Phase 3)Study completedNCT00517309
What this trial is testing

Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 1,877
Large-scale testing (Phase 3)Active Not RecruitingNCT05662020
What this trial is testing

Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 2,750
Testing effectiveness (Phase 2)Ended earlyNCT03610581
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Who this might be right for
Human Papillomavirus Infections
Janssen Vaccines & Prevention B.V. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05450705
What this trial is testing

V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,500
Large-scale testing (Phase 3)Study completedNCT00779766
What this trial is testing

Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 6,081
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Next Page